Compass Financial Advisors LLC Gilead Sciences, Inc. Transaction History

Compass Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $106,069 - $120,845	1,372 Added 42.07%	4,633 $384,000
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $14,956 - $21,472	-240 Reduced 6.86%	3,261 $279,000
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $21,991 - $24,768	-381 Reduced 9.81%	3,501 $216,000
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $23,341 - $29,249	403 Added 11.58%	3,882 $231,000
Q4 2021 Feb 24, 2022	BUY	$64.88 - $73.64 $225,717 - $256,193	3,479 New	3,479 $253,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Compass Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Compass Financial Advisors LLC with notifications on news.